Investor Information

A built product, a proven audience, and a funded relaunch

CareBee 1.0 is finished — 200+ screens, native iOS and Android, four years of development including real-world pilots. And we have 220,000 opted-in contacts from OoWomaniya, our women's health platform in India, which has been trading since 2014. What we are raising is the go-to-market, not the product.

$4MSeed raise for 40% — $10M post-money

Year 2EBITDA break-even at a 14% margin

$131.7MYear-5 revenue at a 54% EBITDA margin

9.3×LTV to paid CAC, 5.6-month payback

Request the deck See the product

Investment thesis

Five reasons this is a different risk profile

01 · Product risk retired

The app is built

CareBee 1.0 exists: 200+ designed screens, native iOS and Android, a clinical-grade backend, and four years of prior development including real-world pilots. Seed capital funds distribution, not discovery.

02 · Distribution advantage

220,000 people already opted in

OoWomaniya, our women's health platform in India, has 220,000 opted-in contacts, 1.74M unique visitors, and 3,500+ completed consultations — built organically since 2014 with no paid marketing. That is a launch list, not a cold start, and it produces a $9 CAC in India against $111 in the US.

03 · Unit economics

$1,028 LTV on $111 paid CAC

A 9.3× ratio with a 5.6-month payback. Blended CAC is $88 once partner channels carry their share, and word-of-mouth (k = 0.54) is modelled as cushion rather than as the plan.

04 · Revenue depth

Five streams, one subscriber

Subscription, expert add-ons, e-commerce, insurance, and B2B2C. Household value grows from $240 to roughly $516 a year without a second acquisition event.

05 · Capital efficiency

$4M covers a $3.18M peak cash need

Peak cumulative cash requirement is $3.18M, leaving $819K of headroom before break-even in Year 2. This is a single-round plan, not a bridge to a bigger round.

Market — two geographies, sized bottom-up

We size the obtainable market from households and price, not from analyst totals. 63 million Americans care for an adult family member — a population that grew 45% in a decade — and the share reporting real difficulty coordinating care has risen from 19% to 26%.

Geography	TAM	SAM	SOM	Basis
United States	$15.1B	$3.6B	$118.6M	230,000 households at $516 blended annual value
India	$71B	$1.4B	$13.1M	OoWomaniya's 220,000 opted-in contacts, $9 CAC, ₹586.89 average order

The SOM is roughly 3% of the US serviceable market. We do not need to win the category to hit the plan — we need 230,000 households out of 63 million.

Traction we already own

All of it from OoWomaniya, our women's health platform in India — trading since 2014, self-funded from revenue, and built with no performance-marketing spend.

220,000Opted-in contacts across platform and community

2.68MPage views, 88.4% mobile — 1.74M uniques

400+Credentialed experts, 3,500+ consultations delivered

25%Repeat purchase rate, ₹586.89 average order value

Commerce, not just an audience

12 brands and 400+ SKUs already trading on a dropship model, with a 25% repeat rate. The e-commerce stream in the model is a live business being extended, not a hypothesis.

Demand peaks we've already absorbed

A peak month of 247,003 unique visitors, served on the same infrastructure. Scale behaviour is observed rather than projected.

40,000+ registered users

Registered, not merely reached — the cohort we convert first, at a fraction of paid-channel cost.

Five-year plan

Revenue and EBITDA in $ millions. Gross margin expands from 60% to 73% as the subscription and add-on mix grows relative to e-commerce.
Metric	Year 1	Year 2	Year 3	Year 4	Year 5
Revenue	4.82	18.58	41.52	79.44	131.73
EBITDA	(3.18)	2.63	14.07	36.67	70.67
EBITDA margin	(66%)	14%	34%	46%	54%

Break-even

Year 2

EBITDA-positive at a 14% margin on $18.58M of revenue.

Peak cash need

$3.18M

Against a $4M raise — $819K of headroom on the plan as written.

Revenue mix shift

60% → 51%

Subscription share of revenue, Year 1 to Year 5, as add-ons and B2B2C scale.

Use of funds — $4M

57% · $2.28M

Sales & marketing

Discharge-planner programs in 8–10 metros, benefits-channel sales, and paid acquisition at a measured CAC.

23% · $920K

Product & engineering

Ambient AI Scribe, insurance and pharmacy integrations, and the FHIR work that connects households to clinical systems.

13% · $520K

Operations & care

Expert network expansion, advocacy delivery, and the support capacity a caregiving product genuinely requires.

7% · $280K

Legal & compliance

HIPAA, insurance licensing, POA instruments, and IP protection across both geographies.

Headcount: 8 today, 18 by the end of Year 1, 42 by Year 3 — weighted toward go-to-market rather than engineering, because the product is already built.

AI-Powered · Blockchain-Secured · Patient-to-Enterprise

The terms

Raise: $4,000,000
Equity offered: 40%
Post-money valuation: $10,000,000
Break-even: Year 2, no follow-on assumed
Contact: db@axinagroup.com

Implied return

19–30× on comparable multiples

Public digital-health comparables trade around 5.4× EV/revenue. Applied to the Year-5 plan, a $10M entry implies a 19–30× outcome. We present the range, not a single number, because the multiple is the variable we don't control.

What de-risks it

Break-even before the money runs out

A $3.18M peak cash need against $4M means the plan does not depend on raising again. Word-of-mouth at k = 0.54 sits outside the model as cushion.

Team

Who is executing this

Daniel Brody — Founder & CEO. Four years building the CareBee architecture, including real-world pilots.
Krutika Katrat — Co-Founder, Head of India Marketing. Co-founder and Director of OoWomaniya, the source of the 220,000-contact base. MSc Biotechnology; formerly a cancer-biology researcher at ACTREC, Tata Memorial Centre.
Benjamin Dach, Ph.D., Esq. — Chief Legal Officer. Health-data compliance, POA instruments, and IP protection.

Asset base

Four years of documented IP

CareBee 1.0 — 200+ designed screens, native iOS and Android

AXERP Health — clinical ERP/HIS with HL7-FHIR R4 exchange

Care Captain™ authority model, cryptographically enforced

Ambient AI Scribe pipeline on AWS HealthScribe, output as coded FHIR

OoWomaniya — a trading India platform: consultation marketplace, 400+ vetted experts, multilingual content library, and a 12-brand / 400+ SKU store

Live partnerships — Thyrocare diagnostics, Karkinos cancer screening, Apollo 24|7 pharmacy

HIPAA, PCI and PIPEDA compliance posture at 99.9% uptime

Full IP schedule, financial model, and pilot documentation available under NDA.

Request the investor materials

The full deck, five-year model, cohort assumptions, and IP schedule are available to qualified investors under NDA.

db@axinagroup.com Use the contact form